ReWalk Robotics And 3 Other Stocks Under $2 Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders have recently bought shares in four penny stocks: VolitionRx Limited (VNRX), Cadrenal Therapeutics, Inc. (CVKD), Origin Materials, Inc. (ORGN), and ReWalk Robotics Ltd. (RWLK). These purchases indicate the insiders' confidence in the companies' prospects. VolitionRx posted a narrower-than-expected quarterly loss, Cadrenal Therapeutics highlighted the need for a new vitamin k antagonist, Origin Materials appointed Pam Haley as interim CFO, and ReWalk Robotics posted downbeat Q2 results.
September 07, 2023 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cadrenal Therapeutics Chairman and CEO Quang Pham acquired 40,000 shares at an average price of $0.90. The company recently highlighted the need for a new vitamin k antagonist.
The insider purchase indicates confidence in the company's prospects, which could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Origin Materials Director R. Tony Tripeny acquired 73,000 shares at an average price of $1.37. The company recently appointed Pam Haley as interim CFO.
The insider purchase indicates confidence in the company's prospects, which could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
ReWalk Robotics 10% owner Lind Global Fund II LP acquired 31,537 shares at an average price of $0.70. The company recently posted downbeat Q2 results.
The insider purchase indicates confidence in the company's prospects, which could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
VolitionRx Director Phillip Barnes acquired 5,000 shares at an average price of $1.30. The company recently posted a narrower-than-expected quarterly loss.
The insider purchase indicates confidence in the company's prospects, which could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100